- Messages
- 8,157
- Dislikes
- soaps on telly and people talking about the characters as if they were real.
This is it. It's not in line with NICE
Across the Thames Valley, the NHS spends approximately £4.4million each year on blood glucose testing reagents, more than that spent on oral antidiabetic drugs. The Thames Valley Priorities Committees have reviewed diabetes guidelines across the Thames Valley on Blood Glucose Testing Reagents and support the recommendations.
Key points were:
• There is little evidence to support self-monitoring of blood glucose in all people with diabetes, and especially those with type 2 disease, unless the purpose is clearly defined within an effective management plan for the patient.
• Self-monitoring is most likely to be most appropriate for patients with type 1 or type 2 diabetes, who use insulin and adjust their dose as a result of the test, or for all patients with diabetes who have inter-current illness.
• Blood testing is recommended for all patients with type 1 diabetes, and for those with type 2 diabetes who use insulin.
• There is no evidence that blood testing is effective at improving blood glucose control in people with type 2 diabetes who do not use insulin. Until further evidence is available from ongoing studies its use should be dictated by specific clinical need.
• Frequency and timing of self-monitoring should be determined individually by the clinical needs of the patient. This may vary from one test every 1-2 weeks, in patients with stable type 2 diabetes, to 3 times a day before meals and again at night for some patients on insulin where there are problems with control or hypoglycaemia.
Type 2 Diabetes Glucose testing guidelines (non insulin dependent)
Stability of Diabetes
Frequency
Suggested units of testing reagents/year
Stable control
Blood glucose 1-2 times a week at different times of the day
2 boxes of strips per year
Unstable control or Titration
Test once daily at different times of the day
7 boxes of strips per year
This statement will be reviewed in light of new evidence or further guidance by NICE (See full NICE guideline )
Across the Thames Valley, the NHS spends approximately £4.4million each year on blood glucose testing reagents, more than that spent on oral antidiabetic drugs. The Thames Valley Priorities Committees have reviewed diabetes guidelines across the Thames Valley on Blood Glucose Testing Reagents and support the recommendations.
Key points were:
• There is little evidence to support self-monitoring of blood glucose in all people with diabetes, and especially those with type 2 disease, unless the purpose is clearly defined within an effective management plan for the patient.
• Self-monitoring is most likely to be most appropriate for patients with type 1 or type 2 diabetes, who use insulin and adjust their dose as a result of the test, or for all patients with diabetes who have inter-current illness.
• Blood testing is recommended for all patients with type 1 diabetes, and for those with type 2 diabetes who use insulin.
• There is no evidence that blood testing is effective at improving blood glucose control in people with type 2 diabetes who do not use insulin. Until further evidence is available from ongoing studies its use should be dictated by specific clinical need.
• Frequency and timing of self-monitoring should be determined individually by the clinical needs of the patient. This may vary from one test every 1-2 weeks, in patients with stable type 2 diabetes, to 3 times a day before meals and again at night for some patients on insulin where there are problems with control or hypoglycaemia.
Type 2 Diabetes Glucose testing guidelines (non insulin dependent)
Stability of Diabetes
Frequency
Suggested units of testing reagents/year
Stable control
Blood glucose 1-2 times a week at different times of the day
2 boxes of strips per year
Unstable control or Titration
Test once daily at different times of the day
7 boxes of strips per year
This statement will be reviewed in light of new evidence or further guidance by NICE (See full NICE guideline )